# Core B - Clinical Sample and Biostatistics Core

> **NIH NIH P01** · MASSACHUSETTS GENERAL HOSPITAL · 2020 · $160,426

## Abstract

Core B- Bob S. Carter PI
Project Summary/ Abstract
The non-invasive diagnosis of human glioma could improve the quality of life of patients with
this disease by allowing patients to be directly diagnosed or stratified for treatment without
the need of an invasive brain biopsy. In Core B, the investigators propose to develop a novel
clinical sample core to study extracellular RNA biomarkers for the diagnosis of human
glioma tumors. In collaboration with the P01 project investigators, we will study EV proteins,
nucleic acids, and physical characteristics as potential biomarkers for glioma diagnosis or
progression. We will work with a consortium of institutions to provide rapid prospective
collection of tumor tissue, CSF, and blood from glioma patients. In additon, the Core will
provide biostatistical support to all Projects.

## Key facts

- **NIH application ID:** 9939465
- **Project number:** 5P01CA069246-23
- **Recipient organization:** MASSACHUSETTS GENERAL HOSPITAL
- **Principal Investigator:** Bob S Carter
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $160,426
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9939465

## Citation

> US National Institutes of Health, RePORTER application 9939465, Core B - Clinical Sample and Biostatistics Core (5P01CA069246-23). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9939465. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*